Ariadne V Ebel1, Gabrielle Lutt2, Jill A Poole1, Geoffrey M Thiele1, Joshua F Baker3, Grant W Cannon4, Angelo Gaffo5, Gail S Kerr6, Andreas Reimold7, Pascale Schwab8, Namrata Singh9, J Steuart Richards10, Dana P Ascherman10, Ted R Mikuls1, Bryant R England1. 1. VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha. 2. VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, and University of Nebraska at Lincoln, Lincoln. 3. Philadelphia VA Medical Center and University of Pennsylvania, Philadelphia. 4. VA Salt Lake City Health Care System and University of Utah, Salt Lake City. 5. Birmingham VA Medical Center and University of Alabama at Birmingham, Birmingham. 6. Washington, DC VA Medical Center, Georgetown University, and Howard University, Washington, DC. 7. Dallas VA Medical Center and University of Texas Southwestern, Dallas. 8. VA Portland Healthcare System and Oregon Health and Science University, Portland. 9. University of Washington, Seattle. 10. VA Pittsburgh Health Care and University of Pittsburgh, Pittsburg, Pennsylvania.
Abstract
OBJECTIVE: To determine the association of inhalant exposures with rheumatoid arthritis (RA)-related autoantibodies and severity in US veterans. METHODS: Participants in the Veterans Affairs Rheumatoid Arthritis (VARA) registry were mailed surveys assessing occupational, agricultural, and military inhalant exposures. Demographic characteristics, disease activity, functional status, and extraarticular features were obtained from the VARA registry, while HLA-DRB1 shared epitope (SE) status, anti-cyclic citrullinated peptide (anti-CCP) antibodies, and rheumatoid factor (RF) were measured using banked DNA/serum from enrollment. Associations between inhalant exposures and RA-related factors (autoantibodies, severity, and extraarticular features) were assessed using multivariable linear and logistic regression models adjusted for age, sex, race, and tobacco use and stratified by SE status. Adjusted odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated. RESULTS: Questionnaires were returned by 797 of 1,566 participants (50.9%). Survey respondents were older, more often White or male, and less frequently smokers, and had lower disease activity compared to nonrespondents. Anti-CCP positivity was more common among veterans exposed to burn pits (OR 1.66 [95% CI 1.02, 2.69]) and military waste disposal (OR 1.74 [95% CI 1.04, 2.93]) independent of other factors. Among participants who were positive for SE alleles, burn pit exposure (OR 5.69 [95% CI 2.73, 11.87]) and military waste disposal exposure (OR 5.05 [95% CI 2.42, 10.54]) were numerically more strongly associated with anti-CCP positivity. Several inhalant exposures were associated with the presence of chronic lung disease, but not with the presence of RF or the level of disease activity. CONCLUSION: Military burn pit exposure and military waste disposal exposure were independently associated with the presence of anti-CCP antibodies in RA patients. These findings are consistent with emerging evidence that various inhalant exposures influence autoantibody expression and RA risk.
OBJECTIVE: To determine the association of inhalant exposures with rheumatoid arthritis (RA)-related autoantibodies and severity in US veterans. METHODS: Participants in the Veterans Affairs Rheumatoid Arthritis (VARA) registry were mailed surveys assessing occupational, agricultural, and military inhalant exposures. Demographic characteristics, disease activity, functional status, and extraarticular features were obtained from the VARA registry, while HLA-DRB1 shared epitope (SE) status, anti-cyclic citrullinated peptide (anti-CCP) antibodies, and rheumatoid factor (RF) were measured using banked DNA/serum from enrollment. Associations between inhalant exposures and RA-related factors (autoantibodies, severity, and extraarticular features) were assessed using multivariable linear and logistic regression models adjusted for age, sex, race, and tobacco use and stratified by SE status. Adjusted odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated. RESULTS: Questionnaires were returned by 797 of 1,566 participants (50.9%). Survey respondents were older, more often White or male, and less frequently smokers, and had lower disease activity compared to nonrespondents. Anti-CCP positivity was more common among veterans exposed to burn pits (OR 1.66 [95% CI 1.02, 2.69]) and military waste disposal (OR 1.74 [95% CI 1.04, 2.93]) independent of other factors. Among participants who were positive for SE alleles, burn pit exposure (OR 5.69 [95% CI 2.73, 11.87]) and military waste disposal exposure (OR 5.05 [95% CI 2.42, 10.54]) were numerically more strongly associated with anti-CCP positivity. Several inhalant exposures were associated with the presence of chronic lung disease, but not with the presence of RF or the level of disease activity. CONCLUSION: Military burn pit exposure and military waste disposal exposure were independently associated with the presence of anti-CCP antibodies in RA patients. These findings are consistent with emerging evidence that various inhalant exposures influence autoantibody expression and RA risk.
Authors: Anthony Szema; Niely Mirsaidi; Bhumika Patel; Laura Viens; Edward Forsyth; Jonathan Li; Sophia Dang; Brittany Dukes; Jheison Giraldo; Preston Kim; Matthew Burns Journal: Am J Mens Health Date: 2015-12-14
Authors: D Makrygiannakis; M Hermansson; A-K Ulfgren; A P Nicholas; A J W Zendman; A Eklund; J Grunewald; C M Skold; L Klareskog; A I Catrina Journal: Ann Rheum Dis Date: 2008-04-15 Impact factor: 19.103
Authors: T R Mikuls; L B Hughes; A O Westfall; V M Holers; L Parrish; D van der Heijde; M van Everdingen; G S Alarcón; D L Conn; B Jonas; L F Callahan; E A Smith; G Gilkeson; G Howard; L W Moreland; S L Bridges Journal: Ann Rheum Dis Date: 2008-01-15 Impact factor: 19.103
Authors: Bryant R England; Michael J Duryee; Punyasha Roul; Tina D Mahajan; Namrata Singh; Jill A Poole; Dana P Ascherman; Liron Caplan; M Kristen Demoruelle; Kevin D Deane; Lynell W Klassen; Geoffrey M Thiele; Ted R Mikuls Journal: Arthritis Rheumatol Date: 2019-07-22 Impact factor: 10.995
Authors: Christine G Parks; Jane A Hoppin; Anneclaire J De Roos; Karen H Costenbader; Michael C Alavanja; Dale P Sandler Journal: Environ Health Perspect Date: 2016-06-10 Impact factor: 9.031
Authors: Ted R Mikuls; Rohit Gaurav; Geoffrey M Thiele; Bryant R England; Madison G Wolfe; Brianna P Shaw; Kristina L Bailey; Todd A Wyatt; Amy J Nelson; Michael J Duryee; Carlos D Hunter; Dong Wang; Debra J Romberger; Dana P Ascherman; Jill A Poole Journal: Int Immunopharmacol Date: 2021-08-27 Impact factor: 4.932
Authors: Jill A Poole; Ted R Mikuls; Geoffrey M Thiele; Rohit Gaurav; Amy J Nelson; Michael J Duryee; Ananya Mitra; Carlos Hunter; Todd A Wyatt; Bryant R England; Dana P Ascherman Journal: Respir Res Date: 2022-06-18